|
|
||||||||
1 Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, Victoria, Australia 3052; and 2 Department of Physiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E5
This study investigated the effect of intracerebroventricular administration of the angiotensin AT1 receptor antagonist losartan on the natriuresis, pressor effect, and arginine vasopressin (AVP) secretion caused by intracerebroventricular infusion of either ANG II, hypertonic saline, or carbachol. Losartan (1 mg/h) or artificial cerebrospinal fluid (CSF) was infused into the lateral ventricle before, during, and after infusions of either ANG II at 10 µg/h for 1 h, 0.75 mol/l NaCl at 50 µl/min for 20 min, or carbachol at 1.66 µg/min for 15 min. Intracerebroventricular infusions of ANG II, 0.75 mol/l NaCl, or carbachol caused increases in renal Na+ and K+ excretion, arterial pressure, and plasma AVP levels. Increases in arterial pressure, Na+ excretion, and plasma AVP concentration ([AVP]) in response to intracerebroventricular ANG II or intracerebroventricular 0.75 mol/l NaCl were either abolished or attenuated by intracerebroventricular infusion of losartan but not by intracerebroventricular infusion of artificial CSF or intravenous losartan. Intracerebroventricular losartan did not reduce the increase in plasma [AVP] or arterial pressure in response to intracerebroventricular carbachol, but it did attenuate the natriuretic response to intracerebroventricular carbachol. We conclude that an intracerebroventricular dose of losartan (1 mg/h) that inhibits responses to intracerebroventricular ANG II also inhibits vasopressin secretion, natriuresis, and the pressor response to intracerebroventricular hypertonic saline. These results suggest that common neural pathways are involved in the responses induced by intracerebroventricular administration of ANG II and intracerebroventricular hypertonic NaCl. We propose that intracerebroventricular infusion of hypertonic saline activates angiotensinergic pathways in the central nervous system subserving the regulation of fluid and electrolyte balance and arterial pressure in sheep.
angiotensin; hypertonicity; sodium excretion; blood pressure; cerebral ventricle
This article has been cited by other articles:
![]() |
F. Shimizu, T. Kasai, and A. Takamata Involvement of central angiotensin II type 1 receptors in LPS-induced systemic vasopressin release and blood pressure regulation in rats J Appl Physiol, June 1, 2009; 106(6): 1943 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Frithiof, S. Eriksson, F. Bayard, T. Svensson, and M. Rundgren Intravenous hypertonic NaCl acts via cerebral sodium-sensitive and angiotensinergic mechanisms to improve cardiac function in haemorrhaged conscious sheep J. Physiol., September 15, 2007; 583(3): 1129 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Cairns, P. Burns, R. Di Nicolantonio, M. J. McKinley, and M. L. Mathai Influence of brain angiotensin on thermoregulation and hydromineral balance during pregnancy in rats J Appl Physiol, May 1, 2005; 98(5): 1813 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Francis, S.-G. Wei, R. M. Weiss, and R. B. Felder Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2138 - H2146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morris, S. Means, M. I. Oliverio, and T. M. Coffman Enhanced central response to dehydration in mice lacking angiotensin AT1a receptors Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1177 - R1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Mathai, T. Hubschle, and M. J. McKinley Central angiotensin receptor blockade impairs thermolytic and dipsogenic responses to heat exposure in rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2000; 279(5): R1821 - R1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. May, R. M. McAllen, and M. J. McKinley Renal nerve inhibition by central NaCl and ANG II is abolished by lesions of the lamina terminalis Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2000; 279(5): R1827 - R1833. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |